Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

M.D. Anderson Cancer Center80 enrolled

Overview

To compare the results of the SOCS-OTS to another standardized screening measure that is currently being used by rehabilitation services at MD Anderson Cancer Center and to ensure that the SOCS-OTS correctly identifies those individuals needing OT services in cancer care.

Primary Aim 1\. Explore the SOCS-OTS for use in the Physical Medicine and Rehabilitation (PM\&R) clinic by means of diagnostic testing including sensitivity and specificity. Secondary Aims 1. Explore whether the SOCS-OTS identifies the likelihood that the presence or absence of OT referral is correctly predicted. To accomplish this, the likelihood ratios, and predictive values of the SOCS-OTS will be assessed. 2. Determine associations between the need for OT and demographic factors such as stage of cancer, cancer treatment etc. 3. Establish test-retest reliability of the SOCS-OTS.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cancer Occupational Therapy

Interventions

Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS)OTHER

Given by Questionnaire

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Must be 18 years an older 2. Currently medically followed in the PMR clinic (with or without acute disease) 3. Must speak and read English. The AM-PAC is currently validated in adults only. Additionally, the assessment tools are in English without translation into other languages, therefore only clients who do speak and read English will be included. Pregnant participants are not excluded. Exclusion Criteria: 1\. Potential participants with confusion and cognitive impairments that might hinder their ability to sign an informed consent form or participate in the study.

Locations (1)

MD Anderson Cancer Center

Houston, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Safety and adverse events (AEs)

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)

Time frame: Through study completion; an average of 1 year.

Central Contacts

Ekta Gupta, MD

CONTACT

(713) 745-2327 egupta@mdanderson.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.